CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 198 filers reported holding CHEMOCENTRYX INC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,292,000 | +84.6% | 141,170 | -11.5% | 0.01% | +66.7% |
| Q2 2022 | $3,950,000 | +56.9% | 159,427 | +58.8% | 0.00% | +200.0% |
| Q1 2022 | $2,517,000 | -48.1% | 100,398 | -24.7% | 0.00% | -66.7% |
| Q4 2021 | $4,853,000 | +39.5% | 133,267 | -34.5% | 0.00% | +50.0% |
| Q3 2021 | $3,480,000 | -21.1% | 203,500 | -38.3% | 0.00% | -33.3% |
| Q2 2021 | $4,413,000 | -24.7% | 329,618 | +188.1% | 0.00% | -25.0% |
| Q1 2021 | $5,863,000 | +652.6% | 114,425 | +809.2% | 0.00% | – |
| Q4 2020 | $779,000 | +125.8% | 12,585 | +99.7% | 0.00% | – |
| Q3 2020 | $345,000 | -97.1% | 6,302 | -96.9% | 0.00% | -100.0% |
| Q2 2020 | $11,863,000 | +693.0% | 206,170 | +453.8% | 0.01% | +800.0% |
| Q1 2020 | $1,496,000 | +94.5% | 37,230 | +91.6% | 0.00% | 0.0% |
| Q4 2019 | $769,000 | +3104.2% | 19,436 | +446.6% | 0.00% | – |
| Q3 2019 | $24,000 | -97.5% | 3,556 | -96.5% | 0.00% | -100.0% |
| Q2 2019 | $957,000 | +907.4% | 102,892 | +1406.7% | 0.00% | – |
| Q1 2019 | $95,000 | +111.1% | 6,829 | +67.7% | 0.00% | – |
| Q4 2018 | $45,000 | -21.1% | 4,073 | -8.9% | 0.00% | – |
| Q3 2018 | $57,000 | +103.6% | 4,473 | +111.9% | 0.00% | – |
| Q2 2018 | $28,000 | -37.8% | 2,111 | -36.3% | 0.00% | – |
| Q1 2018 | $45,000 | +542.9% | 3,315 | +171.1% | 0.00% | – |
| Q4 2017 | $7,000 | -50.0% | 1,223 | -33.6% | 0.00% | – |
| Q3 2017 | $14,000 | +600.0% | 1,843 | +1044.7% | 0.00% | – |
| Q2 2017 | $2,000 | – | 161 | +1688.9% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 9 | -99.9% | 0.00% | – |
| Q3 2016 | $58,000 | +480.0% | 9,593 | +353.4% | 0.00% | – |
| Q2 2016 | $10,000 | -86.1% | 2,116 | -92.6% | 0.00% | – |
| Q1 2016 | $72,000 | +20.0% | 28,642 | +289.3% | 0.00% | – |
| Q4 2015 | $60,000 | – | 7,358 | +183850.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 4 | -99.9% | 0.00% | – |
| Q2 2015 | $48,000 | -14.3% | 5,874 | -20.7% | 0.00% | – |
| Q1 2015 | $56,000 | -42.9% | 7,408 | -48.3% | 0.00% | – |
| Q4 2014 | $98,000 | +2350.0% | 14,342 | +1363.5% | 0.00% | – |
| Q3 2014 | $4,000 | -63.6% | 980 | -49.6% | 0.00% | – |
| Q2 2014 | $11,000 | -76.1% | 1,944 | -72.4% | 0.00% | – |
| Q1 2014 | $46,000 | -33.3% | 7,032 | -40.7% | 0.00% | – |
| Q4 2013 | $69,000 | – | 11,863 | +36971.9% | 0.00% | – |
| Q3 2013 | $0 | – | 32 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |